Kestra Advisory Services’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,640
| Closed | -$86.3K | – | 2832 |
|
|
2024
Q3 | $86.3K | Buy |
23,640
+2,640
| +13% | +$9.64K | ﹤0.01% | 2473 |
|
|
2024
Q2 | $57.3K | Hold |
21,000
| – | – | ﹤0.01% | 2546 |
|
|
2024
Q1 | $73.1K | Hold |
21,000
| – | – | ﹤0.01% | 2383 |
|
|
2023
Q4 | $30K | Hold |
21,000
| – | – | ﹤0.01% | 2242 |
|
|
2023
Q3 | $30.7K | Hold |
21,000
| – | – | ﹤0.01% | 2074 |
|
|
2023
Q2 | $33K | Hold |
21,000
| – | – | ﹤0.01% | 2062 |
|
|
2023
Q1 | $32.1K | Hold |
21,000
| – | – | ﹤0.01% | 2013 |
|
|
2022
Q4 | $35.3K | Hold |
21,000
| – | – | ﹤0.01% | 2198 |
|
|
2022
Q3 | $26K | Sell |
21,000
-2,400
| -10% | -$2.97K | ﹤0.01% | 2065 |
|
|
2022
Q2 | $39K | Buy |
23,400
+2,400
| +11% | +$4K | ﹤0.01% | 2058 |
|
|
2022
Q1 | $52K | Hold |
21,000
| – | – | ﹤0.01% | 1963 |
|
|
2021
Q4 | $79K | Hold |
21,000
| – | – | ﹤0.01% | 1955 |
|
|
2021
Q3 | $132K | Hold |
21,000
| – | – | ﹤0.01% | 2033 |
|
|
2021
Q2 | $207K | Hold |
21,000
| – | – | ﹤0.01% | 1846 |
|
|
2021
Q1 | $196K | Sell |
21,000
-60,767
| -74% | -$567K | ﹤0.01% | 1736 |
|
|
2020
Q4 | $397K | Buy |
+81,767
| New | +$397K | ﹤0.01% | 1324 |
|